Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,344
Closed -$380K 544
2024
Q3
$380K Buy
+3,344
New +$397K 0.18% 120
2024
Q1
Sell
-14,809
Closed -$1.61M 615
2023
Q4
$1.61M Buy
+14,809
New +$1.54M 0.51% 11
2023
Q1
Sell
-2,316
Closed -$257K 365
2022
Q4
$257K Buy
+2,316
New +$237K 0.21% 160
2022
Q3
Sell
-4,304
Closed -$392K 332
2022
Q2
$392K Buy
+4,304
New +$382K 0.37% 89

Other funds holding MRK

Corton Capital's MRK Position: Q4 2024 in Review

Corton Capital sold out of Merck (MRK) in Q4 2024, closing a stake of 3,344 shares — an estimated $380K sold.

Corton Capital first reported a position in MRK in Q2 2022 and held it in 4 quarters. The position peaked at $1.61M in Q4 2023. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Corton Capital reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 3,344 Merck shares in Q4 2024, an estimated $380K.
  • Corton Capital first reported a position in Merck in Q2 2022 and held it in 4 quarters.
  • Corton Capital's Merck position peaked at $1.61M in Q4 2023.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.